UK markets open in 1 hour 55 minutes

Gerresheimer AG (GRRMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
91.850.00 (0.00%)
At close: 10:36AM EST

Gerresheimer AG

Klaus-Bungert-Strasse 4
Düsseldorf 40468
49 211 6181 00

IndustryMedical Instruments & Supplies
Full-time employees10,175

Key executives

NameTitlePayExercisedYear born
Mr. Dietmar SiemssenCEO of Plastics & Devices and Advanced Technologies Division & Chairman of the Management Board1.84MN/A1963
Dr. Bernd Metzner Ph.D.CFO & Member of the Management Board1.24MN/A1970
Dr. Lukas BurkhardtMember of the Management Board1.24MN/A1979
Ms. Katja SchnitzlerMember of Supervisory Board120.03kN/A1981
Ms. Carolin NadiloCorp. Director of Investor RelationsN/AN/AN/A
Mr. Jens KürtenGroup Sr. Director of Communication & Marketing and Press Officer of Corp. MediaN/AN/AN/A
Mr. Helmut SchweigerMD & GM of Gerresheimer Horsovsky Tyn PlantN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Gerresheimer AG, together with its subsidiaries, manufactures and sells specialty glass, plastic products, and drug delivery-devices and solutions primarily worldwide. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables, and components for dialysis machines, and catheters and surgical devices. It also provides containers for the delivery of tablets and powders, liquid dosages, ophthalmic and rhinological applications, parenteral packaging applications, oral prescription medications, and cosmetics. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as ampoules, cartridges, vials, syrup and dropper bottles, tablet jars, and wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, and care and decorative cosmetics; and bottles and jars for spirits and food. The Advanced Technologies division develops drug delivery products and platforms, such as micro pumps, which are used to self-administer medication for heart failure or Parkinson's for pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Corporate governance

Gerresheimer AG’s ISS governance QualityScore as of 26 September 2021 is 4. The pillar scores are Audit: 5; Board: 6; Shareholder rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.